These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 35565407)

  • 1. Clinical Considerations for Immunoparesis in Multiple Myeloma.
    Chahin M; Branham Z; Fox A; Leurinda C; Keruakous AR
    Cancers (Basel); 2022 May; 14(9):. PubMed ID: 35565407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoparesis and polyclonal immunoglobulin recovery after auto-SCT for patients with multiple myeloma treated at a single institution.
    Jimenez-Zepeda VH; Duggan P; Neri P; Chaudhry A; Tay J; Bahlis N
    Leuk Lymphoma; 2018 Aug; 59(8):1920-1926. PubMed ID: 29160734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoparesis defined by heavy/light chain pair suppression in smoldering multiple myeloma shows initial isotype specificity and involves other isotypes in advanced disease.
    Isola I; Moreno DF; Moga E; Mena MP; Tovar N; Rodríguez-Lobato LG; Oliver-Caldés A; Salgado MC; Brasó-Maristany F; Yagüe J; Cibeira MT; Prat A; Rosiñol L; Bladé J; Fernández de Larrea C
    Ann Hematol; 2021 Dec; 100(12):2997-3005. PubMed ID: 34463804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe and continuous immunoparesis during induction or maintenance therapy in nontransplant patients with multiple myeloma is a sign of poor prognosis.
    Chen Y; Chen Z; Cao J; Lin L; Li J
    Hematology; 2024 Dec; 29(1):2329378. PubMed ID: 38470208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterisation and prognostic impact of immunoparesis in relapsed multiple myeloma.
    Chakraborty R; Rybicki L; Nakashima MO; Dean RM; Faiman BM; Samaras CJ; Rosko N; Dysert H; Valent J; Anwer F
    Br J Haematol; 2020 Jun; 189(6):1074-1082. PubMed ID: 32108328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoparesis in symptomatic multiple myeloma at diagnosis affects PFS with bortezomib-containing induction therapy, but not ASCT consolidation.
    Gao W; Li J; Jian Y; Yang G; Wu Y; Li Y; Len Y; Liu A; Tian Y; Wang H; Zhou H; Zhang Z; Chen W
    Int J Hematol; 2019 Feb; 109(2):169-174. PubMed ID: 30311142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoparesis recovery 1 year after ASCT is independently associated with favorable survival in patients with symptomatic multiple myeloma who undergo autologous stem cell transplantation.
    Gao W; Li J; Wu Y; Li Y; Leng Y; Liu A; Yang G; Tian Y; Wang H; Wang G; Wu Z; Ren Z; Chen W
    Ann Hematol; 2019 May; 98(5):1177-1184. PubMed ID: 30610278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Etiological Cytogenetic Abnormalities on the Depth of Immunoparesis and Survival in Newly Diagnosed Multiple Myeloma.
    Caro J; Cairns D; Menzies T; Boyle E; Pawlyn C; Cook G; Kaiser M; Walker BA; Owen R; Jackson GH; Morgan GJ; Heaney J; Drayson MT; Davies FE
    Clin Lymphoma Myeloma Leuk; 2022 Apr; 22(4):e279-e284. PubMed ID: 34876373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials.
    Heaney JLJ; Campbell JP; Iqbal G; Cairns D; Richter A; Child JA; Gregory W; Jackson G; Kaiser M; Owen R; Davies F; Morgan G; Dunn J; Drayson MT
    Leukemia; 2018 Aug; 32(8):1727-1738. PubMed ID: 29925902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoparesis in newly diagnosed Multiple Myeloma patients: Effects on overall survival and progression free survival in the Danish population.
    Sørrig R; Klausen TW; Salomo M; Vangsted AJ; Frølund UC; Andersen KT; Klostergaard A; Helleberg C; Pedersen RS; Pedersen PT; Helm-Petersen S; Teodorescu EM; Preiss B; Abildgaard N; Gimsing P;
    PLoS One; 2017; 12(12):e0188988. PubMed ID: 29216227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deep and partial immunoparesis is a poor prognostic factor for newly diagnosed multiple myeloma patients.
    Geng C; Yang G; Wang H; Wu Y; Leng Y; Zhou H; Zhang Z; Jian Y; Chen W
    Leuk Lymphoma; 2021 Apr; 62(4):883-890. PubMed ID: 33275060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recovery of polyclonal immunoglobulins one year after autologous stem cell transplantation as a long-term predictor marker of progression and survival in multiple myeloma.
    González-Calle V; Cerdá S; Labrador J; Sobejano E; González-Mena B; Aguilera C; Ocio EM; Vidriales MB; Puig N; Gutiérrez NC; García-Sanz R; Alonso JM; López R; Aguilar C; de Coca AG; Hernández R; Hernández JM; Escalante F; Mateos MV
    Haematologica; 2017 May; 102(5):922-931. PubMed ID: 28126960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoparesis and monoclonal gammopathy of undetermined significance are disassociated in advanced age.
    Cherry BM; Costello R; Zingone A; Burris J; Korde N; Manasanch E; Kwok M; Annunziata C; Roschewski MJ; Engels EA; Landgren O
    Am J Hematol; 2013 Feb; 88(2):89-92. PubMed ID: 23169485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial immunoparesis contributes to risk of early infections in patients with multiple myeloma.
    Huang W; Wei X; Wei Q; Wei Y; Feng R
    Transl Cancer Res; 2021 Dec; 10(12):5258-5266. PubMed ID: 35116375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term survival and polyclonal immunoglobulin reconstitution after allogeneic stem cell transplantation in multiple myeloma.
    Eisfeld C; Eßeling E; Wullenkord R; Khandanpour C; Reusch J; Mikesch JH; Reicherts C; Kerkhoff A; Schliemann C; Kessler T; Mesters RM; Berdel WE; Lenz G; Stelljes M
    Ann Hematol; 2020 Aug; 99(8):1907-1915. PubMed ID: 32444892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoparesis defined by heavy+light chain suppression is a novel marker of long-term outcomes in cardiac AL amyloidosis.
    Sachchithanantham S; Berlanga O; Alvi A; Mahmood SA; Lachmann HJ; Gillmore JD; Hawkins PN; Harding S; Wechalekar AD
    Br J Haematol; 2017 Nov; 179(4):575-585. PubMed ID: 28990174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study.
    Cavo M; Gay F; Beksac M; Pantani L; Petrucci MT; Dimopoulos MA; Dozza L; van der Holt B; Zweegman S; Oliva S; van der Velden VHJ; Zamagni E; Palumbo GA; Patriarca F; Montefusco V; Galli M; Maisnar V; Gamberi B; Hansson M; Belotti A; Pour L; Ypma P; Grasso M; Croockewit A; Ballanti S; Offidani M; Vincelli ID; Zambello R; Liberati AM; Andersen NF; Broijl A; Troia R; Pascarella A; Benevolo G; Levin MD; Bos G; Ludwig H; Aquino S; Morelli AM; Wu KL; Boersma R; Hajek R; Durian M; von dem Borne PA; Caravita di Toritto T; Zander T; Driessen C; Specchia G; Waage A; Gimsing P; Mellqvist UH; van Marwijk Kooy M; Minnema M; Mandigers C; Cafro AM; Palmas A; Carvalho S; Spencer A; Boccadoro M; Sonneveld P
    Lancet Haematol; 2020 Jun; 7(6):e456-e468. PubMed ID: 32359506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Monoclonal gammopathy of undetermined significance and asymptomatic multiple myelom in the year 2014 ].
    Adam Z; Krejčí M; Pour L; Sevčíková E; Křivanová A; Rehák Z; Koukalová R; Cermáková Z; Vaníček J; Sevčíková S
    Vnitr Lek; 2014 Oct; 60(10):861-79. PubMed ID: 25382009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoparesis status in immunoglobulin light chain amyloidosis at diagnosis affects response and survival by regimen type.
    Muchtar E; Dispenzieri A; Kumar SK; Dingli D; Lacy MQ; Buadi FK; Hayman SR; Kapoor P; Leung N; Chakraborty R; Russell S; Lust JA; Lin Y; Go RS; Zeldenrust S; Kyle RA; Rajkumar SV; Gertz MA
    Haematologica; 2016 Sep; 101(9):1102-9. PubMed ID: 27479823
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.